4-[3-(5-BROMO-2-PROPOXYPHENYL)-5-(4-CHLOROPHENYL)-1H-PYRROL-2-YL]PYRIDINE
4-[3-(5-BROMO-2-PROPOXYPHENYL)-5-(4-CHLOROPHENYL)-1H-PYRROL-2-YL]PYRIDINE(191034-25-0)
- Name: 4-[3-(5-BROMO-2-PROPOXYPHENYL)-5-(4-CHLOROPHENYL)-1H-PYRROL-2-YL]PYRIDINE
- Synonyms:L 168049
- Molecular Formula:C24H20 Br Cl N2 O
- Molecular Weight:467.793
- CAS Registry Number:191034-25-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.191034-25-0 4-[3-(5-BROMO-2-PROPOXYPHENYL)-5-(4-CHLOROPHENYL)-1H-PYRROL-2-YL]PYRIDINE
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.191034-25-0 4-[3-(5-BROMO-2-PROPOXYPHENYL)-5-(4-CHLOROPHENYL)-1H-PYRROL-2-YL]PYRIDINE
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:4-[3-(5-BROMO-2-PROPOXYPHENYL)-5-(4-CHLOROPHENYL)-1H-PYRROL-2-YL]PYRIDINE
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.191034-25-0 4-[3-(5-BROMO-2-PROPOXYPHENYL)-5-(4-CHLOROPHENYL)-1H-PYRROL-2-YL]PYRIDINE
Assay:98% Appearance:white powder Package:5mg Storage:Keep it in dry,shady and cool place Transportation:by express or by sea Application:Pharma;Industry;Agricultural;chemical reaserch
Min. Order:0
Supplier:Shanghai Yuanye Bio-Technology Co., Ltd. [
China (Mainland)] CAS No.191034-25-0 L-168,049
Assay:鈮?9% by HPLC Package:inquiry Transportation:inquiry Application:L-168,049 is a non-peptidyl, very selective and potent human glucagon receptor (hGR) antagonist. It displays high affinity to human GR with IC50 value of 3.7 nM, but shows moderate affinity for mu...
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 68647-13-2/1,3-Benzenedicarboxylic acid, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, hexanedioic acid and 2,2,4-trimethyl-1,3-pentanediol, benzoate
- 70050-78-1/Protostane
- 58257-95-7/(3S,8S,9S,10S,13R,14S,17R)-13-methyl-17-[(2R)-6-methylheptan-2-yl]-10-(methylselanylmethyl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
- 129679-44-3/dihydro-1,4-ethano-1H,3H-thieno(3,4-c)thiophene-3,6(4H)-dione
- 62666-09-5/4-{[(Z)-(3-fluoro-6-oxocyclohexa-2,4-dien-1-ylidene)(phenyl)methyl]amino}butanamide
- 63474-04-4/1-(benzyloxy)-3-[(1-methylethyl)amino]propan-2-ol (2E)-but-2-enedioate (salt)
- 27665-57-2/Propanoic acid,2-methyl-, 4-[(2R,3R)-3-methyloxiranyl]phenyl ester, rel-(+)- (9CI)
- 73541-92-1/(piperidin-1-ylmethylidene)propanedinitrile
- 131483-45-9/vasotocin, 1-desamino-OEt-Tyr(2)-Val(4)-Orn(8)-
- 60063-88-9/Aminopeptidase,thyrotropin-releasing factor pyroglutamate
- 83359-43-7/2-chloro-6-methyl-6H-benzo[c]chromene-6-carboxylic acid
- 63906-68-3/7-(hydroxymethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione nitrate (1:1)
- 5652-28-8/(+-)-2-AMINO-3-PHOSPHONOPROPIONIC ACID ( AP-3)NMDA ANTAGONIST
- 64070-87-7/sulfanediyldiethane-2,1-diyl bis(thiocyanate)
- 5952-31-8/6-[(3Z)-3-[hydroxy(4-methylphenyl)methylidene]-2-(4-methoxyphenyl)-4,5-dioxopyrrolidin-1-yl]hexanoic acid
- 191034-25-0/4-[3-(5-BROMO-2-PROPOXYPHENYL)-5-(4-CHLOROPHENYL)-1H-PYRROL-2-YL]PYRIDINE
- 136723-26-7/2-chloro-4-methyl-5-propyl-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indole
- 16159-93-6/N-methyl-N-(octan-2-yl)cyclopropanamine
- 92682-27-4/1,1,1-trifluoro-3-(undecylsulfanyl)propan-2-one
- 30781-27-2/Amadinone
- 123154-62-1/[1,1'-Biphenyl]-2,2',4,4',6-pentol,6'-(2,4,6-trihydroxyphenoxy)-
- 13042-80-3/3,4-Dihydro-2H-thiopyran
- 67801-01-8/barium bis[5-chloro-4-ethyl-2-[(2-hydroxy-1-naphthyl)azo]benzenesulphonate]
- 72152-60-4/disodium 6,6'-[(9,10-dihydro-9,10-dioxo-1,4-anthrylene)diimino]bis[4-bromo-3,5-diethyltoluene-2-sulphonate]
- 83959-54-0/6-(prop-2-en-1-ylsulfanyl)-5H-purin-2-amine
- 1513-63-9/5H-purine-6-sulfonyl fluoride
- 9017-09-8/1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 1,3-diisocyanatomethylbenzene
- 65086-67-1/2-(1-oxa-4-azaspiro[4.5]dec-7-yl)ethyl 2-methylprop-2-enoate - methyl 2-methylprop-2-enoate (1:1)
- 2437-47-0/1H-triaziren-1-ylacetic acid
- 5681-57-2/1-butyl-3-hydroxyurea